Ranson, Janice M.
Bucholc, Magda
Lyall, Donald
Newby, Danielle
Winchester, Laura
Oxtoby, Neil P.
Veldsman, Michele
Rittman, Timothy
Marzi, Sarah
Skene, Nathan
Al Khleifat, Ahmad
Foote, Isabelle F.
Orgeta, Vasiliki
Kormilitzin, Andrey
Lourida, Ilianna
Llewellyn, David J.
Funding for this research was provided by:
Alzheimer’s Research UK
the Alan Turing Institute/Engineering and Physical Sciences Research Council (EP/N510129/1, EP/N510129/1, EP/N510129/1)
George Moore Endowment for Data Science at Ulster University
UKRI Future Leaders Fellowship (MR/S03546X/1)
The Motor Neurone Disease Association (MNDA) Fellowship (Al Khleifat/Oct21/975-799)
ALS Association Milton Safenowitz Research Fellowship
George Henry Woolfe Legacy Fund
National Institute for Health Research (NIHR) Applied Research Collaboration (ARC) South West Peninsula
National Health and Medical Research Council
National Institute on Aging/National Institutes of Health (RF1AG055654)
Article History
Received: 31 May 2022
Accepted: 26 December 2022
First Online: 24 February 2023
Declarations
:
: Not applicable.
: Not applicable.
: AK declares research grant funding from GlaxoSmithKline. All other authors declare no competing interests.